Response to comment on Brunnekreef et al.: Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?

被引:0
作者
Brunnekreef, Jaap J. [1 ]
Schreurs, Berend W. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Orthopaed, NL-6500 HB Nijmegen, Netherlands
关键词
ROFECOXIB;
D O I
10.1007/s00264-013-1948-8
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
引用
收藏
页码:1631 / 1631
页数:1
相关论文
共 2 条
[1]   Rofecoxib inhibits heterotopic ossification after total hip arthroplasty [J].
van der Heide, Huub J. L. ;
Koorevaar, Rinco C. T. ;
Lemmens, J. Albert M. ;
van Kampen, Albert ;
Schreurs, B. Willem .
ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2007, 127 (07) :557-561
[2]   Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty [J].
van der Heide, Huub J. L. ;
Rijnberg, Willard J. ;
van Sorge, Adriaan ;
van Kampen, Albert ;
Schreurs, B. Willem .
ACTA ORTHOPAEDICA, 2007, 78 (01) :90-94